Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Cosmetics

  • Print
  • Share
  • E-mail
-

BSE and Cosmetics: FDA Risk Assessment and Management Perspectives - Slide 11. BSE

December 7, 2006

First  |  ← Previous  |  Slide 11 of 45  |  Next →  |  Last  |  Index

Slide 11. BSE - See text below

BSE

  • Issues for Cosmetics
    • Possible vehicle for infection
      • Abraded skin, eye area, mucous membranes
    • Identification of ingredient sources
      • Risk Assessment: tissue, country of origin
        • "Safe-sourcing" from non-BSE countries; non-BSE herds in BSE or BSE-suspect countries
        • Avoid "Co-mingling" and "cross-contamination"
        • Use of SRMs and other "BSE-Risk Materials"
      • Tallow and Tallow Derivatives
      • Gelatin and Gelatin Derivatives
-
-